GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Chunghwa Chemical Synthesis & Biotech Co 1762.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

31.40

+1.45%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 804.9m

FY2016FY2025

Net income

−TWD 243.8m

FY2016FY2025

Free cash flow

TWD 80.3m

FY2016FY2025

Shareholders' equity

TWD 3.09bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 804.9mTWD 1.35bnTWD 2.09bnTWD 2.12bnTWD 1.93bnTWD 1.54bnTWD 1.16bnTWD 1.02bnTWD 1.17bnTWD 1.20bn
Gross profit−TWD 8.9mTWD 394.3mTWD 757.3mTWD 961.8mTWD 949.4mTWD 686.8mTWD 468.6mTWD 351.5mTWD 407.9mTWD 414.5m
Research and developmentTWD 168.3mTWD 205.8mTWD 242.7mTWD 244.8mTWD 252.7mTWD 215.7mTWD 195.5mTWD 161.5mTWD 149.3mTWD 146.4m
Operating income−TWD 319.5mTWD 6.3mTWD 293.0mTWD 468.7mTWD 519.3mTWD 655.1mTWD 154.4mTWD 30.9mTWD 78.1mTWD 98.1m
Net income−TWD 243.8mTWD 53.0mTWD 264.9mTWD 465.9mTWD 400.8mTWD 531.9mTWD 117.0mTWD 234.3mTWD 85.8mTWD 60.3m
Diluted earnings per share-4.400.683.425.905.116.801.513.021.100.78

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 4.32bnTWD 4.76bnTWD 5.17bnTWD 4.56bnTWD 4.38bnTWD 3.15bnTWD 3.44bnTWD 3.22bnTWD 3.45bnTWD 2.73bn
Cash and short-term investmentsTWD 216.4mTWD 222.3mTWD 269.6mTWD 300.6mTWD 195.3mTWD 148.6mTWD 101.2mTWD 106.4mTWD 156.0mTWD 143.1m
Total liabilitiesTWD 1.23bnTWD 1.41bnTWD 1.82bnTWD 1.37bnTWD 1.49bnTWD 648.5mTWD 1.42bnTWD 1.24bnTWD 1.63bnTWD 954.5m
DebtTWD 805.9mTWD 858.2mTWD 1.21bnTWD 604.5mTWD 753.6mTWD 4.3mTWD 896.3mTWD 798.6mTWD 1.19bnTWD 510.2m
Shareholders' equityTWD 3.09bnTWD 3.36bnTWD 3.35bnTWD 3.19bnTWD 2.89bnTWD 2.50bnTWD 2.01bnTWD 1.98bnTWD 1.82bnTWD 1.77bn
Shares outstanding55m78m78m79m78m78m77m78m78m77m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 142.6mTWD 467.7m−TWD 77.5mTWD 733.8mTWD 219.2mTWD 138.2mTWD 268.1mTWD 234.7mTWD 159.3mTWD 261.3m
Capital spending−TWD 62.3m−TWD 104.7m−TWD 450.0m−TWD 376.2m−TWD 405.5m−TWD 193.0m−TWD 114.8m−TWD 93.7m−TWD 805.8m−TWD 114.9m
Free cash flowTWD 80.3mTWD 363.0m−TWD 527.5mTWD 357.6m−TWD 186.3m−TWD 54.7mTWD 153.3mTWD 140.9m−TWD 646.5mTWD 146.5m
Dividends paid−TWD 14.7m−TWD 62.0m−TWD 100.8m−TWD 100.8m−TWD 116.3m−TWD 62.0m−TWD 93.1m−TWD 38.8m−TWD 38.8m−TWD 116.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 305.2mTWD 361.2mTWD 113.4mTWD 154.5mTWD 344.0mTWD 193.0mTWD 286.3mTWD 348.2m
Gross profitTWD 115.7mTWD 150.6m−TWD 89.4m−TWD 9.2mTWD 29.2mTWD 60.5mTWD 71.4mTWD 87.9m
Operating incomeTWD 35.3mTWD 79.6m−TWD 163.0m−TWD 88.4m−TWD 73.8mTWD 8.7m−TWD 3.5m−TWD 4.8m
Net incomeTWD 41.5mTWD 90.6m−TWD 141.3m−TWD 42.6m−TWD 67.3mTWD 7.3m−TWD 361,000−TWD 8.2m
Diluted earnings per share0.751.64-2.55-0.77-1.210.13-0.00-0.11
Cash from operationsTWD 108.0mTWD 90.0m−TWD 20.0mTWD 112.0m−TWD 25.0mTWD 76.0mTWD 191.0mTWD 63.0m
Capital spending−TWD 15.0m−TWD 1.0m−TWD 16.0m−TWD 9.0m−TWD 14.0m−TWD 22.0m−TWD 15.0m−TWD 20.0m
Free cash flowTWD 93.0mTWD 89.0m−TWD 36.0mTWD 103.0m−TWD 39.0mTWD 54.0mTWD 176.0mTWD 43.0m
Total assetsTWD 4.36bnTWD 4.46bnTWD 4.32bnTWD 4.44bnTWD 4.59bnTWD 4.75bnTWD 4.76bnTWD 4.87bn
Cash and short-term investmentsTWD 330.0mTWD 286.5mTWD 216.4mTWD 253.2mTWD 214.1mTWD 275.1mTWD 222.3mTWD 196.8m
DebtTWD 753.7mTWD 802.2mTWD 803.1mTWD 804.5mTWD 855.0mTWD 853.9mTWD 854.2mTWD 1.01bn
Shareholders' equityTWD 3.20bnTWD 3.18bnTWD 3.09bnTWD 3.21bnTWD 3.26bnTWD 3.38bnTWD 3.36bnTWD 3.34bn

Financial ratios

Data as of 29 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin-1.1%29.3%36.3%45.4%49.1%44.5%
Operating margin-29.7%5.8%16.9%27.1%26.8%42.4%
Net margin-30.3%3.9%12.7%22.0%20.7%34.5%
Return on equity-7.9%1.6%7.9%14.6%13.8%21.3%
Return on assets-5.6%1.1%5.1%10.2%9.1%16.9%
Free cash flow yield11.1%22.1%14.4%42.1%23.9%12.7%
Revenue growth-40.3%-35.4%-1.5%9.4%25.3%33.5%
Earnings growth-559.8%-80.0%-43.1%16.2%-24.6%354.6%
Current ratio2.97x3.39x2.15x2.36x2.14x2.50x
Debt to equity0.26x0.25x0.36x0.19x0.26x0.00x
Equity ratio71.5%70.5%64.8%70.0%66.1%79.4%
Interest coverage-14.28x3.69x18.16x59.17x156.36x137.70x
R&D as a share of sales20.9%15.3%11.6%11.6%13.1%14.0%
Buybacks as a share of market value28.5%0.0%1.8%-0.7%-0.2%-1.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-27.6%-12.2%-3.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin17.9%33.1%38.0%37.3%
Operating margin-14.6%7.1%16.5%13.4%
Net margin-8.9%8.5%15.0%14.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-5.649.616.811.112.79.023.47.622.134.8
Price to sales1.71.92.12.52.63.12.41.71.61.8

Dividends and splits

Per share, in the currency the company pays

Paid for 16 years. Last went ex-dividend on 24 Jul 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year0.1920.801.301.301.500.801.200.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.